Stocklytics score rationale: value 70, quality 52, growth 51.
Financials
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
7668400000
7803300000
7932900000
7982200000
6127500000
6827300000
6939900000
7394200000
7678600000
8231500000
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and…
Forecast
Consensus Hold from 28 analysts. Average price target $103.11, +6.2% versus the current price. Low $93.00. High $120.00.
Analysts have an average 12-month price target of $103.11 for Zimmer Biomet Holdings (ZBH), 6.2% above the current price of $97.11. Of 28 analysts covering the stock, 9 rate it Buy or Strong Buy, 19 Hold, and 0 Sell or Strong Sell, giving a consensus of Hold.
Forecasts are third-party estimates and often wrong. They are not investment advice.
ZBH price target
12-month price target
Low
$93.00
Average
$103.11
High
$120.00
The average is 6.2% above the current price of $97.11.
Is Zimmer Biomet Holdings a buy or sell?
Of 28 analysts, 9 rate Zimmer Biomet Holdings Buy or Strong Buy, 19 Hold, and 0 Sell or Strong Sell. The consensus label is Hold. That split is not a recommendation.
Zimmer Biomet Holdings earnings and revenue forecast
The Stocklytics Score for ZBH is 58 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
ZBH forecast FAQs
What is the ZBH price target?
$103.11 average, with a published range of $93.00 to $120.00.
Is Zimmer Biomet Holdings a buy or sell?
The consensus is Hold from 28 analysts. This is not a recommendation.
What is the Zimmer Biomet Holdings stock forecast for 2026?
Analysts' average EPS estimate for 2026 on file is $8.54. The average revenue estimate is $8.60 billion.
What will ZBH be worth in 2030?
No reliable forecast exists that far out.
When is Zimmer Biomet Holdings's next earnings report?
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.